Rocuronium Bromide Injection recall in Canada: medication error risk
In plain language
This recall involves US-labelled Rocuronium Bromide Injection (100 mg/10 mL) sold in Canada. It's being recalled because differences in packaging and volume compared to Canadian products could lead to medication errors. Healthcare professionals should be aware of these differences to prevent harm to patients.
What to do
- Stop using the product immediately.
- Check model/serial numbers if provided.
- Return, repair, or dispose of it as instructed.
- Keep it away from children/pets if the notice indicates a hazard.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Rocuronium Bromide Injection (US-labelled) 100 mg/10 mL (10 mg/mL); 10 mL volume
Why this matters
Medication error risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Medication error risk
What should consumers do?
Stop using the product immediately. Check model/serial numbers if provided. Return, repair, or dispose of it as instructed. Keep it away from children/pets if the notice indicates a hazard.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Medication error risk
When was this product recalled?
This product was recalled on April 29, 2020.